Detalles de la búsqueda
1.
Depression as a possible determinant of fatigue in patients with axial spondyloarthritis.
Clin Exp Rheumatol
; 42(5): 1015-1019, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294018
2.
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs.
Clin Exp Rheumatol
; 42(1): 104-114, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650298
3.
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis.
Rheumatology (Oxford)
; 62(3): 1078-1086, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35920782
4.
High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets.
Clin Exp Rheumatol
; 40(11): 2088-2096, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35238757
5.
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction.
Clin Exp Rheumatol
; 38(3): 420-427, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31577214
6.
Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort.
Rheumatol Int
; 40(2): 263-272, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31435754
7.
Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA.
Clin Exp Rheumatol
; 37(4): 649-655, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30767865
8.
The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus Conference.
Rheumatology (Oxford)
; 57(57 Suppl 7): vii11-vii22, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30289537
9.
Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome.
Blood
; 137(21): 2989-2992, 2021 05 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33649771
10.
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis.
Clin Exp Rheumatol
; 35(2): 241-246, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27908302
11.
Using a modified Delphi process to establish clinical consensus for the diagnosis, risk assessment and abatacept treatment in patients with aggressive rheumatoid arthritis.
Clin Exp Rheumatol
; 35(5): 772-776, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28281459
12.
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries.
Clin Exp Rheumatol
; 35(4): 660-665, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28516879
13.
Tuberculosis Infection Despite Isoniazid Prophylaxis in a Patient With Psoriatic Arthritis Treated With Etanercept.
J Clin Rheumatol
; 25(5): e74-e75, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29280825
14.
Comparison and potential determinants of health-related quality of life among rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: A cross-sectional study.
J Psychosom Res
; 175: 111512, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37844390
15.
Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study.
J Clin Med
; 12(3)2023 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36769604
16.
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study.
Arthritis Res Ther
; 25(1): 196, 2023 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37821952
17.
Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options.
Clin Rheumatol
; 41(4): 1247-1254, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35031874
18.
Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases.
Sci Rep
; 12(1): 22603, 2022 12 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36585438
19.
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study.
Ther Adv Musculoskelet Dis
; 14: 1759720X221090310, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35510168
20.
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis.
Adv Rheumatol
; 61(1): 57, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34526144